Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy

Fig. 3

The receiver operating characteristic curve and calibration curves for testing set. a The receiver operating characteristic curve with AUC 0.6849 (95% CI: 0.6048–0.765). b The calibration curve. ‘Low risk’ is the TLN risk less than 5%; ‘mid risk’ is the TLN risk between 5 and 10%; ‘high risk’ is the TLN risk large than 10%

Back to article page